CatalystPit

NKTRNEKTAR THERAPEUTICS

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $60.55 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$2.07B
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-25 · Brainard Diana (Director) · OTHER
  • 2026-09-25 · CHESS ROBERT (Director) · OTHER
  • 2026-09-25 · GREER R SCOTT (Director) · OTHER
  • 2026-09-25 · Ajer Jeffrey Robert (Director) · OTHER
  • 2026-09-25 · WHITFIELD ROY A (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders253
Shares held52,878,920
Value$2.55B
Percent of shares outstanding154.87%
As of quarter end2026-06-30
RECENT NEWS
  • Nektar Therapeutics (NKTR) Shareholder/Analyst Call - Slideshow
  • Nektar Therapeutics downgraded to hold on REZPEG market outlook
  • H.C. Wainwright reiterates Nektar Therapeutics stock rating on alopecia data
  • Nektar Therapeutics (NKTR) Shareholder/Analyst Call Transcript
  • Nektar Therapeutics presents biomarker data for rezpegaldesleukin
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS